CEACAM5 and neoplasm: Yazaki et al. developed a prototype anti-CEA-swPEG-IR800 conjugate with improved blood circulation half-life and tumor sensitivity, enhancing optical imaging for intraoperative visualization of CEA-expressing GI cancers [69].